Study highlights need for induction strategy in elderly, frail MM patientsDecember 28, 2017Multiple Myeloma
Iron chelating agent could enhance chemo in AMLDecember 28, 2017Leukemia, Myelodysplasia, TransplantationAML
Research explains why cisplatin causes hearing lossDecember 28, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Drug receives fast track, orphan designations for PTCLDecember 27, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
FDA grants orphan designation to drug for AMLDecember 27, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Nilotinib label updated with info on discontinuationDecember 23, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Chemo-free combo should be option for rel/ref CLL, doc saysDecember 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Risk stratification may be possible with JCAR017December 21, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA expands approved use of bosutinib in CMLDecember 20, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML